UPenn has made a $100 million commitment to establish the Center for Precision Engineering for Health said to bring together researchers to develop novel therapeutic biomaterials.
Article from Penn Today
Philadelphia’s startup scene is ranked amongst the best-performing in the world according to Startup Genome.
Article from Philadelphia Business Journal
The U.S. Food and Drug Administration has approved Opzelura™ cream for short-term and non-continuous chronic treatment of atopic dermatitis.
Article from Business Wire
Penn Medicine is one of 30 sites chosen by the National Institute of Health to serve as an Impact of Genomic Variation on Function investigator.
Article from Penn Medicine
The FDA has cleared a company attempting to use CRISPR gene-editing to cure HIV to begin clinical trials.
Article from Endpoints News
Rite Aid Corp. signed a lease for a 23,500 square foot space at 1200 Intrepid Ave for their “enterprise headquarters” as part of an effort to redefine how they envision their employees working as a result of the pandemic.
Article from Philadelphia Business Journal
Temple, Drexel, and other Pennsylvania schools are named as the top colleges in the nation according to the U.S. News & World Report.
Article from Philadelphia Business Journal
Roche’s Genetech has signed a deal to partner with Adaptimmune on off-the-shelf T cell therapies.
Article from Endpoints News
Director of the University of Pennsylvania’s gene therapy program, Dr. James Wilson, has formed a company specializing in gene editing.
Article from Philadelphia Business Journal
